Emerald Advisers, LLC Inovio Pharmaceuticals, Inc. Transaction History

Emerald Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$1.97 - $3.72 $43,241 - $81,654	-21,950 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$2.29 - $4.1 $72,295 - $129,436	-31,570 Reduced 58.99%	21,950 $65,000
Q4 2018 Jan 30, 2019	SELL	$3.89 - $6.11 $72,373 - $113,676	-18,605 Reduced 25.8%	53,520 $214,000
Q3 2018 Oct 31, 2018	BUY	$3.92 - $5.58 $55,193 - $78,566	14,080 Added 24.26%	72,125 $401,000
Q2 2018 Jul 31, 2018	BUY	$3.88 - $5.16 $225,214 - $299,512	58,045 New	58,045 $228,000
Q4 2017 Feb 05, 2018	SELL	$4.13 - $6.68 $83,933 - $135,757	-20,323 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$5.36 - $6.37 $108,931 - $129,457	20,323	20,323 $129,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $566M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.